(Q65369987)

English

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

ENESTFreedom (English)
0 references
A Single-arm, Multicenter, Nilotinib Treatment-free Remission Study in Patients With BCR-ABL1 Positive Chronic Myelogenous Leukemia in Chronic Phase Who Have Achieved Durable Minimal Residual Disease (MRD) Status on First Line Nilotinib Treatment. (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
4 March 2013
0 references
31 May 2016
0 references
221
0 references
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit